Clinical Trial Detail

NCT ID NCT01351103
Title A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

head and neck cancer

cervical squamous cell carcinoma

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

pancreatic cancer

lung squamous cell carcinoma

esophagus squamous cell carcinoma


colorectal cancer

pancreatic adenocarcinoma

Advanced Solid Tumor



LGK974 + Spartalizumab

Age Groups: senior adult

Additional content available in CKB BOOST